Cognitive Research Corporation

Contract research organization running Phase I-III central nervous system clinical trials for pharma and biotech sponsors

+ Add to sales board

Highlights

  • New on EvolcAdded 2026-11-11

About Cognitive Research Corporation

Cognitive Research Corporation (CRC) is a contract research organization (CRO) focused exclusively on Phase I-III central nervous system (CNS) clinical trials. Its services include clinical trial management, trial design, quality assurance, biostatistics, medical writing, data management and rater services, and it offers driving simulation to assess how medications affect driving safety.

Its customers are sponsors developing CNS therapies, and the company also maintains relationships with investigative sites, including more than 300 CNS-focused sites. It sells contract research services to these sponsors.

CRC was founded in 2006 and is headquartered in St. Petersburg, Florida. Its open roles include Senior Director, Business Development and Medical Monitor - CNS, both remote in the US.

Product: Contract research services for CNS clinical trials, including trial management, design, biostatistics, data management, medical writing, rater services and driving simulation studies.

Jobs at Cognitive Research Corporation

No open positions listed right now.

More biotech & pharma companies

  • Corcept Therapeutics

    Develops cortisol-modulating medicines for patients with serious diseases
    United StatesBiotech & pharma2 open jobs
  • Countable Labs

    Single-molecule PCR instruments, assays and testing services for genomics and life-science researchers
    Palo Alto, United StatesBiotech & pharma1 open job
    Remote-friendly
  • Cresilon

    Develops plant-based hemostatic gels for emergency medicine and veterinary care
    United StatesBiotech & pharma
    New on Evolc
  • CSBio

    Automated peptide synthesizers for labs, pilot plants and GMP manufacturers, from benchtop to 1000 L scale
    Mountain View, United StatesBiotech & pharma
    New on Evolc
  • Definium Therapeutics

    Develops psychedelic-derived medicines for people with psychiatric and neurodevelopmental disorders
    United StatesBiotech & pharma
    New on Evolc
  • Disc Medicine

    Clinical-stage biopharma developing first-in-class therapies for hematologic disorders, from rare blood diseases to chronic conditions
    Watertown, United StatesBiotech & pharma
    New on Evolc

All biotech & pharma companies →

Website technologies

Tools and platforms detected on this company’s website, grouped by purpose. Dates record when Evolc observed them.

Backend

  • Ruby on RailsMedium confidence
    First detected
    Last detected
    Last checked
    Detection evidence

Content delivery

  • CloudflareHigh confidence
    First detected
    Last detected
    Last checked
    Detection evidence
  • FastlyHigh confidence
    First detected
    Last detected
    Last checked
    Detection evidence

Content management

  • WordPressHigh confidence
    First detected
    Last detected
    Last checked
    Detection evidence

Forms

  • Contact Form 7High confidence
    First detected
    Last detected
    Last checked
    Detection evidence

Frontend frameworks

  • jQueryHigh confidence
    First detected
    Last detected
    Last checked
    Detection evidence
  • Tailwind CSSMedium confidence
    First detected
    Last detected
    Last checked
    Detection evidence

Hosting

  • nginxHigh confidence
    First detected
    Last detected
    Last checked
    Detection evidence

Marketing & advertising

  • LinkedIn InsightMedium confidence
    First detected
    Last detected
    Last checked
    Detection evidence

Privacy & consent

  • CookieYesHigh confidence
    First detected
    Last detected
    Last checked
    Detection evidence

Recruiting

  • TeamtailorHigh confidence
    First detected
    Last detected
    Last checked
    Detection evidence

Website detection does not establish a paid subscription or company-wide use. Tools loaded after consent or sign-in may be missed. “No longer observed” does not prove the company stopped using a tool.